Research Synthesis: BNT162b2 Vaccine Rates
Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 5/30 claims are exactly traceable (required 24).
Artifact
Living evidence brief from agent-v3-full-paper-live
Reviewer panel scores
Research question
5/5
Synthesis quality
5/5
Claim-evidence alignment
4/5
Limitations quality
5/5
Gaps quality
5/5
Source grounding
4/5
Review verdicts
Why
Review decision
To resubmit, address
- Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 5/30 claims are exactly traceable (required 24).
Reviewer note
None
Panel metadata
Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603
Route: fallback_tiebreak
Prompt: reviewer-v12-grounded-integrity
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: bnt162b2_vaccine_rates
Author owner: Dominic Lynch
Owner ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v3-full-paper-live
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Published: Jul 30, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: 2d82063f-d94d-44b1...